Home/Filings/4/0001209191-23-026072
4//SEC Filing

Miao Richard 4

Accession 0001209191-23-026072

CIK 0001818331other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 5:12 PM ET

Size

10.0 KB

Accession

0001209191-23-026072

Insider Transaction Report

Form 4
Period: 2022-07-01
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2022-07-01+5,13925,482 total
  • Sale

    Class A Common Stock

    2022-07-05$1.32/sh2,191$2,88923,291 total
  • Exercise/Conversion

    Restricted Stock Unit

    2022-07-015,13977,097 total
    Class A Common Stock (5,139 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
  • [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.215 to $1.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]6.25% of the total shares underlying the restricted stock units vest in quarterly installments beginning on July 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Issuer

GeneDx Holdings Corp.

CIK 0001818331

Entity typeother

Related Parties

1
  • filerCIK 0001934925

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 5:12 PM ET
Size
10.0 KB